CLONAL HEMATOPOIESIS

Clinical trials for CLONAL HEMATOPOIESIS explained in plain language.

Never miss a new study

Get alerted when new CLONAL HEMATOPOIESIS trials appear

Sign up with your email to follow new studies for CLONAL HEMATOPOIESIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1

New oral drug could stop blood condition from turning into cancer

Disease control Not yet recruiting

This study tests a low-dose oral drug (decitabine with tetrahydrouridine) in 80 people aged 60-85 with a high-risk blood condition called CCUS, which often leads to blood cancer. The drug aims to reduce harmful blood cell mutations and restore normal blood production without the …

Matched conditions: CLONAL HEMATOPOIESIS

Phase: PHASE2 • Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

CLONAL HEMATOPOIESIS

Get alerted when new CLONAL HEMATOPOIESIS trials appear

New oral drug could stop blood condition from turning into cancer